{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:27:56Z","timestamp":1771468076391,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"unspecified","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,9,29]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The hepatitis C virus (HCV) is a highly infectious and deadly disease, affecting some 58\u2009million people worldwide. Of the 1.13\u2009million people living in the Balearic Islands, Spain, about 1350 individuals have untreated HCV. Of these, about 1120 (83%) are estimated to be people who use drugs (PWUD), who are one of the key at-risk groups for HCV infection globally. Carrying out micro-elimination approaches focused on this population is crucial to achieve the WHO goal of eliminating HCV by 2030. Thus, the primary objective of this study is to validate a model of care that simplifies the screening and linkage to HCV care pathways for PWUD on the Balearic Islands.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This intervention study will be implemented across 17 sites, in 4 different settings: addiction service centres (n=12), non-governmental organisation centres (n=3), a mobile methadone unit and a prison, with an estimated 3725 participants. Together with the healthcare staff at each centre, the intervention protocols will be adapted, focusing on four phases: recruitment and testing; linkage to care; treatment for those who test positive; and monitoring of sustained virological response 12 weeks after treatment and reinfection. The primary outcomes will be the number of tested and treated individuals and the secondary outcomes will include individuals lost at each step in the cascade of care. Descriptive analysis and multivariable logistic regression of the data will be undertaken.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The Hospital Cl\u00ednic Barcelona, Spain, Ethics Committee approved this study on 18 February 2021 (HCB\/2020\/2018). Findings will be disseminated through peer-reviewed publications, conference presentations and social media. The results of this study could provide a model for targeting PWUD for HCV testing and treatment in the rest of Spain and in other settings, helping to achieve the WHO HCV elimination goal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-053394","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T12:54:55Z","timestamp":1634820895000},"page":"e053394","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9618-2299","authenticated-orcid":false,"given":"Jeffrey V","family":"Lazarus","sequence":"first","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Herranz","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-662X","authenticated-orcid":false,"given":"Camila A","family":"Picchio","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Villota-Rivas","sequence":"additional","affiliation":[{"name":"Barcelona Institute for Global Health (ISGlobal), Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Servicio m\u00e9dico, Centro Penitenciario de Mallorca, Palma de Mallorca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Alonso","sequence":"additional","affiliation":[{"name":"Unitat de Conductes Addictives 4 (IBSalut), Palma de Mallorca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Moratinos","sequence":"additional","affiliation":[{"name":"Unitat de Conductes Addictives, Institut d\u2019Afers Socials Mallorqu\u00ed (IMAS), Palma de Mallorca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Perrotta","sequence":"additional","affiliation":[{"name":"Sector m\u00e8dic, Projecte Home Balears, Illes Balears, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Tegeo","sequence":"additional","affiliation":[{"name":"Sector m\u00e8dic, Projecte Home Balears, Illes Balears, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Bibiloni","sequence":"additional","affiliation":[{"name":"Pla d\u2019addiccions i drogodepend\u00e8ncies de les Illes Balears (PADIB), Conselleria de Salut i Consum, Govern de les Illes Balears, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-3078","authenticated-orcid":false,"given":"Maria","family":"Buti","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"},{"name":"CIBER-EHD, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c0ngels","family":"Vilella","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hospital Universitari Son Ll\u00e0tzer, Palma de Mallorca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"2025121409043278000_11.10.e053394.1","unstructured":"World Health Organization . Hepatitis C: key facts, 2019. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c [Accessed 12 Mar 2021]."},{"key":"2025121409043278000_11.10.e053394.2","unstructured":"World Health Organization . Progress report on HIV; viral hepatitis and sexually transmitted infections, 2021. Available: https:\/\/apps.who.int\/iris\/handle\/10665\/342813"},{"key":"2025121409043278000_11.10.e053394.3","unstructured":"Ministry of Health, Social Services and Equality . HCV infection screening guide, 2020. Available: https:\/\/www.mscbs.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/sida\/docs\/GUIA_DE_CRIBADO_DE_LA_INFECCION_POR_EL_VHC_2020.pdf [Accessed 12 Mar 2021]."},{"key":"2025121409043278000_11.10.e053394.4","doi-asserted-by":"crossref","first-page":"103031","DOI":"10.1016\/j.drugpo.2020.103031","article-title":"Telemedicine efficiently improves access to hepatitis C management to achieve HCV elimination in the penitentiary setting","volume":"88","author":"Cuadrado","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2025121409043278000_11.10.e053394.5","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2025121409043278000_11.10.e053394.6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","article-title":"The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study","volume":"4","author":"Trickey","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121409043278000_11.10.e053394.7","unstructured":"Observatorio Espa\u00f1ol de las Drogas y las Adicciones . Informe 2020 alcohol, tabaco Y drogas ilegales en Espa\u00f1a, 2020. Available: https:\/\/pnsd.sanidad.gob.es\/profesionales\/sistemasInformacion\/informesEstadisticas\/pdf\/2020OEDA-INFORME.pdf [Accessed 12 Mar 2021]."},{"key":"2025121409043278000_11.10.e053394.8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.37201\/req\/030.2020","article-title":"Is the universal population hepatitis C virus screening a cost-effective strategy? a systematic review of the economic evidence","volume":"33","author":"Ledesma","year":"2020","journal-title":"Rev Esp Quimioter"},{"key":"2025121409043278000_11.10.e053394.9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121409043278000_11.10.e053394.10","unstructured":"World Health Organization . Accelerating access to hepatitis C diagnostics and treatment: overcoming barriers in low and middle-income countries [Internet], 2021. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240019003 [Accessed 12 Mar 2021]."},{"key":"2025121409043278000_11.10.e053394.11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1666841"},{"key":"2025121409043278000_11.10.e053394.12","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2025121409043278000_11.10.e053394.13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.17235\/reed.2020.7194\/2020","article-title":"Linkage to care strategy for the micro-elimination of hepatitis C among parenteral drug users on methadone replacement therapy in Gipuzkoa","volume":"112","author":"P\u00e9rez Casta\u00f1o","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"2025121409043278000_11.10.e053394.14","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/jvh.13375","article-title":"Innovative procedures for micro-elimination of HCV infection in persons who use drugs","volume":"27","author":"Messina","year":"2020","journal-title":"J Viral Hepat"},{"key":"2025121409043278000_11.10.e053394.15","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/liv.14166","article-title":"Hcv point-of-care screening programme and treatment options for people who use drugs in a metropolitan area of southern Italy","volume":"39","author":"Persico","year":"2019","journal-title":"Liver Int"},{"key":"2025121409043278000_11.10.e053394.16","doi-asserted-by":"crossref","first-page":"103055","DOI":"10.1016\/j.drugpo.2020.103055","article-title":"Hcv testing and treatment initiation in an Italian prison setting: a step-by-step model to micro-eliminate hepatitis C","volume":"90","author":"Fiore","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2025121409043278000_11.10.e053394.17","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1604221"},{"key":"2025121409043278000_11.10.e053394.18","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14779"},{"key":"2025121409043278000_11.10.e053394.19","unstructured":"Government Delegation for the National Plan on Drugs . National strategy on addictions, 2017. Available: https:\/\/pnsd.sanidad.gob.es\/pnsd\/estrategiaNacional\/docs\/ESTRATEGIA_ADICCIONES_2017-2024_en_ingles.pdf [Accessed 22 Apr 2021]."},{"key":"2025121409043278000_11.10.e053394.20","unstructured":"Ministry of Health, Social Services and Equality . Strategic plan for tackling hepatitis C in the Spanish National health system, 2015. Available: https:\/\/www.mscbs.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/hepatitisC\/PlanEstrategicoHEPATITISC\/docs\/PEAHC_eng.pdf [Accessed 12 Mar 2021]."},{"key":"2025121409043278000_11.10.e053394.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.06.016"},{"key":"2025121409043278000_11.10.e053394.22","unstructured":"World Health Organization . Global health sector strategy on viral hepatitis 2016-2021, 2016. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246177\/WHO-HIV-2016.06-eng.pdf?sequence=1 [Accessed 12 Mar 2021]."},{"key":"2025121409043278000_11.10.e053394.23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/joim.12972","article-title":"We know DAAs work, so now what? simplifying models of care to enhance the hepatitis C cascade","volume":"286","author":"Lazarus","year":"2019","journal-title":"J Intern Med"},{"key":"2025121409043278000_11.10.e053394.24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/liv.13949","article-title":"Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework","volume":"39","author":"Day","year":"2019","journal-title":"Liver Int"},{"key":"2025121409043278000_11.10.e053394.25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugpo.2019.05.012","article-title":"Point-of-care hepatitis C testing from needle and syringe programs: an Australian feasibility study","volume":"72","author":"Williams","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025121409043278000_11.10.e053394.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0177-z"},{"key":"2025121409043278000_11.10.e053394.27","unstructured":"Picchio C , Roel E , Buti M . Late presentation of chronic hepatitis B and C virus in people who inject drugs in Spain despite unrestricted access to HBV and HCV therapy. INHSU 2019;abstract 229.doi:10.13140\/RG.2.2.14609.79208"},{"key":"2025121409043278000_11.10.e053394.28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/00333549071220S214","article-title":"Project echo: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico","volume":"122 Suppl 2","author":"Arora","year":"2007","journal-title":"Public Health Rep"},{"key":"2025121409043278000_11.10.e053394.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0157-x"},{"key":"2025121409043278000_11.10.e053394.30","unstructured":"Alianza para la eliminaci\u00f3n de las hepatitis v\u00edricas en Espa\u00f1a. objetivo, 2021. Available: http:\/\/aehve.org\/objetivo-2021\/ [Accessed 12 Mar 2021]."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-053394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:04:43Z","timestamp":1765731883000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-053394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,21]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bmjopen-2021-053394"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-053394","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}